This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huang, R.-Y. Articles by Kowalski, D. Search for Related Content PubMed PubMed Citation Articles by Huang, R.-Y. Articles by Kowalski, D.

Genome-Wide Screen Identifies Genes Whose Inactivation Confer Resistance to Cisplatin in Saccharomyces cerevisiae

Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York

Requests for reprints: Ruea-Yea Huang, Department of Cancer Genetics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. Phone: 716-845-4454; Fax: 716-845-1968; E-mail: raya.huang{at}roswellpark.org.

To identify novel genes that mediate cellular resistance to cisplatin, we have screened the collection of Saccharomyces cerevisiae deletion strains. We have found reproducibly 22 genes/open reading frames (ORF), which when deleted, confer resistance to cisplatin at a concentration that is lethal to wild-type cells. Complementation of individual deletion strains with the corresponding wild-type gene abolished cisplatin resistance, confirming that specific gene deletions caused the resistance. Twenty of the genes/ORFs identified have not been previously linked to cisplatin resistance and belong to several distinct functional groups. Major functional groups encode proteins involved in nucleotide metabolism, mRNA catabolism, RNA-polymerase-II–dependent gene regulation and vacuolar transport systems. In addition, proteins that function in ubiquitination, sphingolipid biogenesis, cyclic AMP–dependent signaling, DNA repair, and genome stability are also associated with cisplatin resistance. More than half of the identified genes are known to have sequences or functional homology to mammalian counterparts. Some deletion strains are cross-resistant to selected cytotoxic agents whereas hypersensitive to others. The sensitivity of certain resistant strains to other cytotoxic agents suggests that our findings may point to particular drug combinations that can overcome resistance caused by inactivation of specific genes.

This article has been cited by other articles:

				G. I. Chen, S. Tisayakorn, C. Jorgensen, L. M. D'Ambrosio, M. Goudreault, and A.-C. Gingras PP4R4/KIAA1622 Forms a Novel Stable Cytosolic Complex with Phosphoprotein Phosphatase 4 J. Biol. Chem., October 24, 2008; 283(43): 29273 - 29284. [Abstract] [Full Text] [PDF]

				D. Kowalski, L. Pendyala, B. Daignan-Fornier, S. B. Howell, and R.-Y. Huang Dysregulation of Purine Nucleotide Biosynthesis Pathways Modulates Cisplatin Cytotoxicity in Saccharomyces cerevisiae Mol. Pharmacol., October 1, 2008; 74(4): 1092 - 1100. [Abstract] [Full Text] [PDF]

				A. Stepanov, K. C. Nitiss, G. Neale, and J. L. Nitiss Enhancing Drug Accumulation in Saccharomyces cerevisiae by Repression of Pleiotropic Drug Resistance Genes with Chimeric Transcription Repressors Mol. Pharmacol., August 1, 2008; 74(2): 423 - 431. [Abstract] [Full Text] [PDF]

				G. Chamilos, R. E. Lewis, G. A. Lamaris, N. D. Albert, and D. P. Kontoyiannis Genomewide Screening for Genes Associated with Gliotoxin Resistance and Sensitivity in Saccharomyces cerevisiae Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1325 - 1329. [Abstract] [Full Text] [PDF]

				L. Xia, L. Jaafar, A. Cashikar, and H. Flores-Rozas Identification of Genes Required for Protection from Doxorubicin by a Genome-Wide Screen in Saccharomyces cerevisiae Cancer Res., December 1, 2007; 67(23): 11411 - 11418. [Abstract] [Full Text] [PDF]

				N. Van Driessche, H. Alexander, J. Min, A. Kuspa, S. Alexander, and G. Shaulsky Global transcriptional responses to cisplatin in Dictyostelium discoideum identify potential drug targets PNAS, September 25, 2007; 104(39): 15406 - 15411. [Abstract] [Full Text] [PDF]

				C. Liao, B. Hu, M. J. Arno, and B. Panaretou Genomic Screening in Vivo Reveals the Role Played by Vacuolar H+ ATPase and Cytosolic Acidification in Sensitivity to DNA-Damaging Agents Such as Cisplatin Mol. Pharmacol., February 1, 2007; 71(2): 416 - 425. [Abstract] [Full Text] [PDF]

				R.-Y. Huang, D. Kowalski, H. Minderman, N. Gandhi, and E. S. Johnson Small Ubiquitin-Related Modifier Pathway Is a Major Determinant of Doxorubicin Cytotoxicity in Saccharomyces cerevisiae Cancer Res., January 15, 2007; 67(2): 765 - 772. [Abstract] [Full Text] [PDF]